TY - JOUR
T1 - TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
AU - NYGC ALS Consortium
AU - Brown, Anna Leigh
AU - Wilkins, Oscar G.
AU - Keuss, Matthew J.
AU - Hill, Sarah E.
AU - Zanovello, Matteo
AU - Lee, Weaverly Colleen
AU - Bampton, Alexander
AU - Lee, Flora C.Y.
AU - Masino, Laura
AU - Qi, Yue A.
AU - Bryce-Smith, Sam
AU - Gatt, Ariana
AU - Hallegger, Martina
AU - Fagegaltier, Delphine
AU - Phatnani, Hemali
AU - Phatnani, Hemali
AU - Kwan, Justin
AU - Sareen, Dhruv
AU - Broach, James R.
AU - Simmons, Zachary
AU - Arcila-Londono, Ximena
AU - Lee, Edward B.
AU - Van Deerlin, Vivianna M.
AU - Shneider, Neil A.
AU - Fraenkel, Ernest
AU - Ostrow, Lyle W.
AU - Baas, Frank
AU - Zaitlen, Noah
AU - Berry, James D.
AU - Malaspina, Andrea
AU - Fratta, Pietro
AU - Cox, Gregory A.
AU - Thompson, Leslie M.
AU - Finkbeiner, Steve
AU - Dardiotis, Efthimios
AU - Miller, Timothy M.
AU - Chandran, Siddharthan
AU - Pal, Suvankar
AU - Hornstein, Eran
AU - MacGowan, Daniel J.
AU - Heiman-Patterson, Terry
AU - Hammell, Molly G.
AU - Patsopoulos, Nikolaos A.
AU - Butovsky, Oleg
AU - Dubnau, Joshua
AU - Crary, John
AU - Lange, Dale J.
AU - Raj, Towfique
AU - Raj, Towfique
AU - Humphrey, Jack
N1 - Funding Information:
We thank F. Allain for the His-tagged TDP-43 plasmid; C. Stuani, F. Weissmann, M. Watson and K. Stott for guidance on TDP-43 purification and ITC; A. Isaacs and P. Whiting for support with shRNA experiments; N. Seyfried for input on proteomic experiments; and J. Vargas for his scientific insights and engaging conversations. This work was supported by grants from UK Medical Research Council MR/R005184/1 (E.M.C.F. and P.F.), FC001002 (J.U.); NIH U54NS123743 (P.F.); UK Motor Neurone Disease Association (P.F.); Rosetrees Trust (P.F. and A.G.); Chan Zuckerberg Initiative (M.E.W.); The Robert Packard Center for ALS Research (M.E.W., P.F. and E.M.C.F.); AriSLA (E.B.); Alzheimers Society (A.G.); NIH T32 GM136577 (S.S.); NIH National Institute of Aging R56-AG055824 and U01-AG068880 (J.H. and T.R.) European Union’s Horizon 2020 research and innovation programme 835300 (J.U.); Cancer Research UK FC001002 (J.U.); Wellcome Trust FC001002 (J.U.); Collaborative Center for X-linked Dystonia-Parkinsonism (W.C.L. and E.M.C.F.). P.F. is supported by a UK Medical Research Council Senior Clinical Fellowship and Lady Edith Wolfson Fellowship (MR/M008606/1 and MR/S006508/1), the UCLH NIHR Biomedical Research Centre; M.E.W. and S.E.H. are supported by the NIH Intramural Research Program of the National Institutes of Neurological Disorders and Stroke; O.G.W. is supported by a Wellcome Trust Studentship; M.Z. is supported by the Neurological Research Trust; S.C. is supported by NIH Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development; A.B. is supported by Eisai and the Wolfson Foundation; S.E.H. is supported by a Brightfocus Foundation postdoctoral research fellowship; T.L. is supported by an Alzheimer’s Research UK senior fellowship; G.S. is supported by a Wellcome Trust Investigator Award (107116/Z/15/Z) and UK Dementia Research Institute Foundation award (UKDRI-1005); M.S. is supported by a UKRI Future Leaders Fellowship (MR/T042184/1); S.B.-S. is supported by a UK Motor Neurone Disease Association and Masonic Charitable Foundation PhD Studentship (893-792); M.H. is supported by a Lady Edith Wolfson Senior Non-Clinical Fellowship (959-799); S.S. is supported by the NIH Oxford–Cambridge Scholars Program.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/3/3
Y1 - 2022/3/3
N2 - Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.
AB - Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia1–3, two related neurodegenerative diseases defined by mislocalization of the RNA-binding protein TDP-434,5. Here we show that TDP-43 depletion induces robust inclusion of a cryptic exon in UNC13A, resulting in nonsense-mediated decay and loss of UNC13A protein. Two common intronic UNC13A polymorphisms strongly associated with amyotrophic lateral sclerosis and frontotemporal dementia risk overlap with TDP-43 binding sites. These polymorphisms potentiate cryptic exon inclusion, both in cultured cells and in brains and spinal cords from patients with these conditions. Our findings, which demonstrate a genetic link between loss of nuclear TDP-43 function and disease, reveal the mechanism by which UNC13A variants exacerbate the effects of decreased TDP-43 function. They further provide a promising therapeutic target for TDP-43 proteinopathies.
UR - http://www.scopus.com/inward/record.url?scp=85125039190&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-04436-3
DO - 10.1038/s41586-022-04436-3
M3 - Article
C2 - 35197628
AN - SCOPUS:85125039190
SN - 0028-0836
VL - 603
SP - 131
EP - 137
JO - Nature
JF - Nature
IS - 7899
ER -